{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T02:11:26Z","timestamp":1793931086272,"version":"4.8.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,7]],"date-time":"2025-12-07T00:00:00Z","timestamp":1765065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000},"content-version":"vor","delay-in-days":36,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-025-67102-y","type":"journal-article","created":{"date-parts":[[2025,12,7]],"date-time":"2025-12-07T07:14:48Z","timestamp":1765091688000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Influenza vaccines promote humoral and cellular immune responses: a randomized, double-blind, phase 3 trial"],"prefix":"10.1038","volume":"17","author":[{"given":"Linmar","family":"Rodr\u00edguez-Guilarte","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constanza","family":"M\u00e9ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonia","family":"Reyes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana","family":"Rios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisca","family":"Rom\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Moreno-Tapia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Cabrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela B.","family":"Rivera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristi\u00e1n","family":"Guti\u00e9rrez-Vera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo A.","family":"Palacios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8339-779X","authenticated-orcid":false,"given":"Andrea","family":"Schilling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7749-3611","authenticated-orcid":false,"given":"Sofia","family":"Aljaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisca","family":"Bascur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1lvaro","family":"Rojas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constanza","family":"del R\u00edo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2600-630X","authenticated-orcid":false,"given":"Patricio","family":"Astudillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos M.","family":"Perez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loreto","family":"Perez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maite","family":"Oyonarte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia E.","family":"Fern\u00e1ndez V\u00e1squez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa M.","family":"Feijoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Beltr\u00e1n Campos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Tovar De Sousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Castej\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvana","family":"Grand\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcela","family":"Villarroel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00eda","family":"Jara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loreto","family":"Twele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Ang\u00e9lica Dom\u00ednguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 V.","family":"Gonz\u00e1lez-Aramundiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Javiera","family":"\u00c1lvarez-Figueroa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanqi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianqian","family":"Xin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2037-7158","authenticated-orcid":false,"given":"Leandro J.","family":"Carre\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Calvo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan M.","family":"Bueno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hern\u00e1n F.","family":"Pe\u00f1aloza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7709-6870","authenticated-orcid":false,"given":"Pablo A.","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis M.","family":"Kalergis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,7]]},"reference":[{"key":"67102_CR1","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1016\/j.vaccine.2021.11.080","volume":"40","author":"J Paget","year":"2022","unstructured":"Paget, J. et al. Estimates of mortality associated with seasonal influenza for the European Union from the GLaMOR project. Vaccine 40, 1361\u20131369 (2022).","journal-title":"Vaccine"},{"key":"67102_CR2","doi-asserted-by":"crossref","unstructured":"Liu, Y., Liu, T., Yao, M., Kou, Z. & Li, R. Exploring barriers to influenza vaccine uptake and recommendation among healthcare providers in the community in China: a qualitative study. Hum Vaccines Immunother 20, 2352916 (2024).","DOI":"10.1080\/21645515.2024.2352916"},{"key":"67102_CR3","doi-asserted-by":"crossref","unstructured":"Bl\u00fcmel, J. et al. Influenza virus. Transfusion Medicine and Hemotherapy 36, 32\u201339 (2009).","DOI":"10.1159\/000197314"},{"key":"67102_CR4","doi-asserted-by":"crossref","unstructured":"Petrova, V. N. & Russell, C. A. The evolution of seasonal influenza viruses. Nat. Rev. Microbiol. 16, 47\u201360 (2018).","DOI":"10.1038\/nrmicro.2017.118"},{"key":"67102_CR5","doi-asserted-by":"crossref","unstructured":"Wang, Y., Tang, C. Y. & Wan, X. F. Antigenic characterization of influenza and SARS-CoV-2 viruses. Anal. Bioanal. Chem. 414, 2841\u20132881 (2022).","DOI":"10.1007\/s00216-021-03806-6"},{"key":"67102_CR6","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1056\/NEJMp2314801","volume":"390","author":"AS Monto","year":"2024","unstructured":"Monto, A. S., Zambon, M. & Weir, J. P. The end of B\/Yamagata influenza transmission\u2014transitioning from quadrivalent vaccines. N. Engl. J. Med. 390, 1256\u20131258 (2024).","journal-title":"N. Engl. J. Med."},{"key":"67102_CR7","doi-asserted-by":"crossref","unstructured":"Nuwarda, R. F., Alharbi, A. A. & Kayser, V. An overview of influenza viruses and vaccines. Vaccines 9 (2021).","DOI":"10.3390\/vaccines9091032"},{"key":"67102_CR8","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1016\/j.vaccine.2011.12.098","volume":"30","author":"C Reed","year":"2012","unstructured":"Reed, C., Meltzer, M. I., Finelli, L. & Fiore, A. Public health impact of including two lineages of influenza B in a quadrivalent seasonal influenza vaccine. Vaccine 30, 1993\u20131998 (2012).","journal-title":"Vaccine"},{"key":"67102_CR9","doi-asserted-by":"publisher","first-page":"4933","DOI":"10.1016\/j.vaccine.2022.06.078","volume":"40","author":"Y Zhang","year":"2022","unstructured":"Zhang, Y. et al. Immunogenicity and safety of an egg culture-based quadrivalent inactivated non-adjuvanted subunit influenza vaccine in subjects \u22653 years: a randomized, multicenter, double-blind, active-controlled phase III, non-inferiority trial. Vaccine 40, 4933\u20134941 (2022).","journal-title":"Vaccine"},{"key":"67102_CR10","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1016\/j.vaccine.2014.01.022","volume":"32","author":"JC Tinoco","year":"2014","unstructured":"Tinoco, J. C. et al. Immunogenicity, reactogenicity, and safety of inactivated quadrivalent influenza vaccine candidate versus inactivated trivalent influenza vaccine in healthy adults aged \u226518 years: a phase III, randomized trial. Vaccine 32, 1480\u20131487 (2014).","journal-title":"Vaccine"},{"key":"67102_CR11","doi-asserted-by":"publisher","unstructured":"Han, Z. et al. Broadly protective CD8+ T cell immunity to highly conserved epitopes elicited by heat shock protein gp96-adjuvanted influenza monovalent split vaccine. J. Virol. 95, https:\/\/doi.org\/10.1128\/jvi.00507-21 (2021).","DOI":"10.1128\/jvi.00507-21"},{"key":"67102_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/srep26494","volume":"6","author":"S-E Bentebibel","year":"2016","unstructured":"Bentebibel, S.-E. et al. ICOS+PD-1+CXCR3+ T follicular helper cells contribute to the generation of high-avidity antibodies following influenza vaccination. Sci. Rep. 6, 26494 (2016).","journal-title":"Sci. Rep."},{"key":"67102_CR13","doi-asserted-by":"crossref","unstructured":"Ritzau-Jost, J. & Hutloff, A. T cell\/b cell interactions in the establishment of protective immunity. Vaccines 9, (2021).","DOI":"10.3390\/vaccines9101074"},{"key":"67102_CR14","doi-asserted-by":"publisher","first-page":"892","DOI":"10.3390\/vaccines12080892","volume":"12","author":"W Yang","year":"2024","unstructured":"Yang, W. et al. Immunogenicity and safety of a quadrivalent influenza vaccine in population aged 3 years and older in Chile and the Philippines: a phase 3, non-inferiority, double-blind, randomized controlled clinical trial. Vaccines 12, 892 (2024).","journal-title":"Vaccines"},{"key":"67102_CR15","unstructured":"Therapeutic Goods Administration (TGA) Australian Government Department of Health. https:\/\/www.tga.gov.au\/."},{"key":"67102_CR16","doi-asserted-by":"publisher","DOI":"10.1002\/eji.202551848","volume":"55","author":"F Rom\u00e1n","year":"2025","unstructured":"Rom\u00e1n, F. et al. T cell response evaluation after a fifth dose of an inactivated SARS-CoV-2 vaccine using multiparametric flow cytometry. Eur. J. Immunol. 55, e51848 (2025).","journal-title":"Eur. J. Immunol."},{"key":"67102_CR17","doi-asserted-by":"publisher","first-page":"e0222381","DOI":"10.1371\/journal.pone.0222381","volume":"14","author":"S Caini","year":"2019","unstructured":"Caini, S. et al. The epidemiological signature of influenza B virus and its B\/Victoria and B\/Yamagata lineages in the 21st century. PLoS One 14, e0222381 (2019).","journal-title":"PLoS One"},{"key":"67102_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-019-4621-z","volume":"19","author":"S Puzelli","year":"2019","unstructured":"Puzelli, S. et al. Co-circulation of the two influenza B lineages during 13 consecutive influenza surveillance seasons in Italy, 2004\u20132017. BMC Infect. Dis. 19, 990 (2019).","journal-title":"BMC Infect. Dis."},{"key":"67102_CR19","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1073\/pnas.1916585116","volume":"117","author":"RK Virk","year":"2020","unstructured":"Virk, R. K. et al. Divergent evolutionary trajectories of influenza B viruses underlie their contemporaneous epidemic activity. Proc. Natl Acad. Sci. 117, 619\u2013628 (2020).","journal-title":"Proc. Natl Acad. Sci."},{"key":"67102_CR20","doi-asserted-by":"publisher","DOI":"10.1111\/irv.13172","volume":"17","author":"M Kang","year":"2023","unstructured":"Kang, M. et al. The impact of pre-existing influenza antibodies and inflammatory status on the influenza vaccine responses in older adults. Influenza Other Respir. Viruses 17, e13172 (2023).","journal-title":"Influenza Other Respir. Viruses"},{"key":"67102_CR21","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/s41591-022-01690-w","volume":"28","author":"M Auladell","year":"2022","unstructured":"Auladell, M. et al. Influenza virus infection history shapes antibody responses to influenza vaccination. Nat. Med 28, 363\u2013372 (2022).","journal-title":"Nat. Med"},{"key":"67102_CR22","doi-asserted-by":"publisher","first-page":"2213","DOI":"10.1016\/j.vaccine.2018.02.022","volume":"36","author":"SM Tete","year":"2018","unstructured":"Tete, S. M. et al. Impact of pre-existing immunity on the induction of functional cross-reactive anti-hemagglutinin stalk antibodies following vaccination with an AS03 adjuvanted pandemic H1N1 vaccine. Vaccine 36, 2213\u20132219 (2018).","journal-title":"Vaccine"},{"key":"67102_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-24090-z","volume":"12","author":"K Miyauchi","year":"2021","unstructured":"Miyauchi, K. et al. Influenza virus infection expands the breadth of antibody responses through IL-4 signalling in B cells. Nat. Commun. 12, 3789 (2021).","journal-title":"Nat. Commun."},{"key":"67102_CR24","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1016\/j.vaccine.2011.12.107","volume":"30","author":"AM Iorio","year":"2012","unstructured":"Iorio, A. M. et al. Influenza viruses and cross-reactivity in healthy adults: Humoral and cellular immunity induced by seasonal 2007\/2008 influenza vaccination against vaccine antigens and 2009 A(H1N1) pandemic influenza virus. Vaccine 30, 1617\u20131623 (2012).","journal-title":"Vaccine"},{"key":"67102_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-13-544","volume":"13","author":"MT Herrera","year":"2013","unstructured":"Herrera, M. T. et al. Humoral and cellular responses to a non-adjuvanted monovalent H1N1 pandemic influenza vaccine in hospital employees. BMC Infect. Dis. 13, 544 (2013).","journal-title":"BMC Infect. Dis."},{"key":"67102_CR26","doi-asserted-by":"publisher","first-page":"8606","DOI":"10.1016\/j.vaccine.2011.09.019","volume":"29","author":"YD Mahnke","year":"2011","unstructured":"Mahnke, Y. D. et al. Age-related changes in durability and function of vaccine-elicited influenza-specific CD4+ T-cell responses. Vaccine 29, 8606\u20138614 (2011).","journal-title":"Vaccine"},{"key":"67102_CR27","doi-asserted-by":"publisher","first-page":"e2574","DOI":"10.1371\/journal.pone.0002574","volume":"3","author":"X-S He","year":"2008","unstructured":"He, X.-S. et al. Baseline levels of influenza-specific CD4 memory T-cells affect t-cell responses to influenza vaccines. PLoS One 3, e2574 (2008).","journal-title":"PLoS One"},{"key":"67102_CR28","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2023.2236537","volume":"19","author":"I Sanz-Mu\u00f1oz","year":"2023","unstructured":"Sanz-Mu\u00f1oz, I. et al. Long-term influenza antibodies profiles in previously vaccinated and non-vaccinated adults. Hum. Vaccin Immunother. 19, 2236537 (2023).","journal-title":"Hum. Vaccin Immunother."},{"key":"67102_CR29","doi-asserted-by":"crossref","unstructured":"Yu, E. D. et al. Balanced cellular and humoral immune responses targeting multiple antigens in adults receiving a quadrivalent inactivated influenza vaccine. Vaccines 9, (2021).","DOI":"10.20944\/preprints202104.0072.v1"},{"key":"67102_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-27064-3","volume":"12","author":"K Wild","year":"2021","unstructured":"Wild, K. et al. Pre-existing immunity and vaccine history determine hemagglutinin-specific CD4 T cell and IgG response following seasonal influenza vaccination. Nat. Commun. 12, 6720 (2021).","journal-title":"Nat. Commun."},{"key":"67102_CR31","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1093\/infdis\/jiz433","volume":"222","author":"KA Richards","year":"2020","unstructured":"Richards, K. A. et al. Evidence that blunted CD4 T-cell responses underlie deficient protective antibody responses to influenza vaccines in repeatedly vaccinated human subjects. J. Infect. Dis. 222, 273\u2013277 (2020).","journal-title":"J. Infect. Dis."},{"key":"67102_CR32","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.virol.2014.12.033","volume":"479\u2013480","author":"SM Kahan","year":"2015","unstructured":"Kahan, S. M., Wherry, E. J. & Zajac, A. J. T cell exhaustion during persistent viral infections. Virology 479\u2013480, 180\u2013193 (2015).","journal-title":"Virology"},{"key":"67102_CR33","doi-asserted-by":"publisher","first-page":"e23698","DOI":"10.1371\/journal.pone.0023698","volume":"6","author":"LE Wagar","year":"2011","unstructured":"Wagar, L. E., Gentleman, B., Pircher, H., McElhaney, J. E. & Watts, T. H. Influenza-specific T cells from older people are enriched in the late effector subset and their presence inversely correlates with vaccine response. PLoS One 6, e23698 (2011).","journal-title":"PLoS One"},{"key":"67102_CR34","doi-asserted-by":"crossref","unstructured":"Tsang, T. K. et al. Investigation of CD4 and CD8 T cell-mediated protection against influenza A virus in a cohort study. BMC Med. 20 (2022).","DOI":"10.1186\/s12916-022-02429-7"},{"key":"67102_CR35","doi-asserted-by":"publisher","first-page":"17757","DOI":"10.1073\/pnas.2004783117","volume":"117","author":"HY Liao","year":"2020","unstructured":"Liao, H. Y. et al. Chimeric hemagglutinin vaccine elicits broadly protective CD4 and CD8 T cell responses against multiple influenza strains and subtypes. Proc. Natl. Acad. Sci. USA 117, 17757\u201317763 (2020).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"67102_CR36","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1111\/j.1365-3083.2007.02042.x","volume":"67","author":"EK Krnic","year":"2008","unstructured":"Krnic, E. K. et al. Enumeration of Haemagglutinin-specific CD8+ T Cells after Influenza Vaccination Using MHC Class I Peptide Tetramers. Scand. J. Immunol. 67, 86\u201394 (2008).","journal-title":"Scand. J. Immunol."},{"key":"67102_CR37","doi-asserted-by":"crossref","unstructured":"Yan-Yang Tao Jing-Xin Li, Y.-M. H. Y.-S. H. G. Z. & Zhu, F.-C. Quadrivalent influenza vaccine (Sinovac Biotech) for seasonal influenza prophylaxis. Expert Rev. Vaccines 20, 1\u201311 (2021).","DOI":"10.1080\/14760584.2021.1875823"},{"key":"67102_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/14760584.2018.1407650","volume":"17","author":"V Gresset-Bourgeois","year":"2018","unstructured":"Gresset-Bourgeois, V. et al. Quadrivalent inactivated influenza vaccine (VaxigripTetraTM). Expert Rev. Vaccines 17, 1\u201311 (2018).","journal-title":"Expert Rev. Vaccines"},{"key":"67102_CR39","doi-asserted-by":"crossref","unstructured":"Montomoli, E., Torelli, A., Manini, I. & Gianchecchi, E. Immunogenicity and safety of the new inactivated quadrivalent influenza vaccine Vaxigrip Tetra: preliminary results in children \u22656 months and older adults. Vaccines 6, (2018).","DOI":"10.3390\/vaccines6010014"},{"key":"67102_CR40","doi-asserted-by":"crossref","unstructured":"Snape, N. et al. Vaccine strain affects seroconversion after influenza vaccination in COPD patients and healthy older people. NPJ Vaccines 7, (2022).","DOI":"10.1038\/s41541-021-00422-4"},{"key":"67102_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-019-13055-y","volume":"10","author":"AC Belkina","year":"2019","unstructured":"Belkina, A. C. et al. Automated optimized parameters for T-distributed stochastic neighbor embedding improve visualization and analysis of large datasets. Nat. Commun. 10, 1\u201312 (2019).","journal-title":"Nat. Commun."},{"key":"67102_CR42","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/nbt.2594","volume":"31","author":"ED Amir","year":"2013","unstructured":"Amir, E. D. et al. viSNE enables visualization of high dimensional single-cell data and reveals phenotypic heterogeneity of leukemia. Nat. Biotechnol. 31, 545\u2013552 (2013).","journal-title":"Nat. Biotechnol."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-67102-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-67102-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-67102-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T10:43:11Z","timestamp":1768473791000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-67102-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,7]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["67102"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-67102-y","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,7]]},"assertion":[{"value":"27 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Funding was received from Sinovac Biotech Co., Ltd.; W.Y., is employed by Sinovac Biotech Co., Ltd.; Q.Q.X. is employed by Sinovac Life Sciences Co., Ltd. The other authors report no conflicts of interest relevant to this article.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"407"}}